Surfactant protein D protects against acute hyperoxic lung injury

American Journal of Respiratory and Critical Care Medicine

Volumn 178, Issue 8, 2008, Pages 805-813

  Jain, Deepika ^a   Atochina Vasserman, Elena N ^a   Tomer, Yaniv ^a   Kadire, Helchem ^a   Beers, Michael F ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Antioxidants; Collectin; Inflammation; Innate immunity; Oxidative stress

Indexed keywords

DOXYCYCLINE; GLUTATHIONE PEROXIDASE 2; HEMOXYGENASE 1; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; OXYGENASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (QUINONE); REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (QUINONE) OXIDOREDUCTASE 1; SURFACTANT PROTEIN D; TRANSCRIPTION FACTOR NRF2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CYTOKINE; RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HISTOPATHOLOGY; HYPEROXIA; LUNG EDEMA; LUNG INJURY; LUNG LAVAGE; MALE; MOUSE; NEUTROPHILIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL; BIOSYNTHESIS; CHEMISTRY; COMPARATIVE STUDY; DISEASE MODEL; FEMALE; GENE EXPRESSION; GENETICS; IMMUNOBLOTTING; METABOLISM; OXIDATIVE STRESS; POLYACRYLAMIDE GEL ELECTROPHORESIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CYTOKINES; DISEASE MODELS, ANIMAL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; GENE EXPRESSION; HYPEROXIA; IMMUNOBLOTTING; MALE; MICE; MICE, TRANSGENIC; OXIDATIVE STRESS; PULMONARY SURFACTANT-ASSOCIATED PROTEIN D; RATS; RESPIRATORY DISTRESS SYNDROME, ADULT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA;

EID: 54049129258     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.200804-582OC     Document Type: Article

References (57)

1. Rooney SA, Young SL, Mendelson CR. Molecular and cellular processing of lung surfactant. FASEB J 1994;8:957-967.
2. Beers MF, Mulugeta S. Surfactant proteins B and C (SP-B and SP-C). In: Lauren GJ, Shapiro SD, editors. Encyclopedia of respiratory medicine. Oxford, UK: Elvesier Limited; 2006. pp. 148-152.
3. Griese M. Pulmonary surfactant in health and human lung diseases: state of the art. Eur Respir J 1999;13:1455-1476.
4. Crouch E, Wright JR. Surfactant proteins A and D and pulmonary host defense. Annu Rev Physiol 2001;63:521-554.
5. White CW, Greene KE, Allen CB, Shannon JM. Elevated expression of surfactant proteins in newborn rats during adaptation to hyperoxia. Am J Respir Cell Mol Biol 2001;25:51-59.
6. Tino MJ, Wright JR. Surfactant protein A stimulates actin polymerization in alveolar macrophages but not peripheral blood monocytes. Am J Respir Crit Care Med 1996;153:A663.
7. Crouch EC, Persson A, Griffin GL, Chang D, Senior RM. Interactions of pulmonary surfactant protein-D (Sp-D) with human blood leukocytes. Am J Respir Cell Mol Biol 1995;12:410-415.
8. Hartshorn KL, Crouch E, White MR, Colamussi ML, Kakkanatt A, Tauber B, Shepherd V, Sastry KN. Pulmonary surfactant proteins A and D enhance neutrophil uptake of bacteria. Am J Physiol Lung Cell Mol Physiol 1998;274:L958-L969.
9. Madan T, Eggleton P, Kishore U, Strong P, Aggrawal SS, Sarma PU, Reid KB. Binding of pulmonary surfactant proteins A and D to Aspergillus fumigatus conidia enhances phagocytosis and killing by human neutrophils and alveolar macrophages. Infect Immun 1997;65:3171-3179.
10. Harrod KS, Trapnell BC, Otake K, Korfhagen TR, Whitsett JA. SP-A enhances viral clearance and inhibits inflammation after pulmonary adenoviral infection. Am J Physiol Lung Cell Mol Physiol 1999;277:L580-L588.
11. Borron PJ, Crouch EC, Lewis JF, Wright JR, Possmayer F, Fraher LJ. Recombinant rat surfactant-associated protein D inhibits human T lymphocyte proliferation and IL-2 production. J Immunol 1998;161:4599-4603.
12. Atochina EN, Gow AJ, Beck JM, Haczku A, Inch A, Kadire H, Tomer Y, Davis C, Preston AM, Poulain F, et al. Delayed clearance of Pneumocystis carinii infection, increased inflammation, and altered nitric oxide metabolism in lungs of surfactant protein D knockout mice. J Infect Dis 2004;189:1528-1539.
13. Boggaram V. Regulation of surfactant protein gene expression by hyperoxia in the lung. Antioxid Redox Signal 2004;6:185-190.
14. Casey J, Kaplan J, Atochina-Vasserman EN, Gow AJ, Kadire H, Tomer Y, Fisher JH, Hawgood S, Savani RC, Beers MF. Alveolar surfactant protein D content modulates bleomycin-induced lung injury. Am J Respir Crit Care Med 2005;172:869-877.
15. Botas C, Poulain F, Akiyama J, Brown C, Allen L, Goerke J, Clements J, Carlson E, Gillespie AM, Epstein C, et al. Altered surfactant homeostasis and alveolar type II cell morphology in mice lacking surfactant protein D. Proc Natl Acad Sci USA 1998;95:11869-11874.
16. Holm BA, Notter RH, Siegle J, Matalon S. Pulmonary physiological and surfactant changes during injury and recovery from hyperoxia. J Appl Physiol 1985;59:1402-1409.
17. Horowitz S, Shapiro DL, Finkelstein JN, Notter RH, Johnston CJ, Quible DJ. Changes in gene-expression in hyperoxia-induced neonatal lung injury. Am J Physiol 1990;258:L107-L111.
18. Jain D, Atochina-Vasserman E, Kadire H, Tomer Y, Inch A, Scott P, Savani RC, Gow AJ, Beers MF. SP-D-deficient mice are resistant to hyperoxia. Am J Physiol Lung Cell Mol Physiol 2007;292:L861-L871.
19. Jain D, Atochina-Vasserman EN, Kadire H, Tomer Y, Inch A, Beers MF. Surfactant protein D protects against hyperoxia-induced acute lung injury in a murine model. FASEB J 2006;20:A1441-A1442.
20. Fisher JH, Sheftelyevich V, Ho YS, Fligiel S, McCormack FX, Korfhagen TR, Whitsett JA, Ikegami M. Pulmonary-specific expression of SP-D corrects pulmonary lipid accumulation in SP-D gene-targeted mice. Am J Physiol Lung Cell Mol Physiol 2000;278:L365-L373.
21. Zhang L, Ikegami M, Dey CR, Korfhagen TR, Whitsett JA. Reversibility of pulmonary abnormalities by conditional replacement of surfactant protein D (SP-D) in vivo. J Biol Chem 2002;277:38709-38713.
22. Atochina EN, Beers MF, Scanlon ST, Preston AM, Beck JMP. Carinii induces selective alterations in component expression and biophysical activity of lung surfactant. Am J Physiol Lung Cell Mol Physiol 2000;278:L599-L609.
23. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
24. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959;37:911-917.
25. Bartlett GR. Phosphorus assay in column chromatography. J Biol Chem 1959;234:466-468.
26. Fisher AB, Dodia C, Tan ZT, Ayene I, Eckenhoff RG. Oxygen-dependent lipid-peroxidation during lung ischemia. J Clin Invest 1991;88:674-679.
27. Enhorning G. Pulmonary surfactant function studied with the pulsating bubble surfactometer (PBS) and the capillary surfactometer (CS). Comp Biochem Physiol A Mol Integr Physiol 2001;129:221-226.
28. Beers MF. Oxygen therapy and pulmonary oxygen toxicity. In: Fishman AP, editor. Pulmonary diseases and disorders, 4th ed. New York: McGraw-Hill; 2008. pp. 2613-2630.
29. Gardai SJ, Xiao YQ, Dickinson M, Nick JA, Voelker DR, Greene KE, Henson PM. By binding SIRP alpha or calreticulin/CD91, lung collectins act as dual function surveillance molecules to suppress or enhance inflammation. Cell 2003;115:13-23.
30. White MR, Crouch E, Vesona J, Tacken PJ, Batenburg JJ, Leth-Larsen R, Holmskov U, Hartshorn KL. Respiratory innate immune proteins differentially modulate the neutrophil respiratory burst response to influenza A virus. Am J Physiol Lung Cell Mol Physiol 2005;289:L606-L616.
31. Eggleton P, Reid KBM. Lung surfactant proteins involved in innate immunity. Curr Opin Immunol 1999;11:28-33.
32. Wang JY, Reid KB. The immunoregulatory roles of lung surfactant collectins SP-A, and SP-D, in allergen-induced airway inflammation. Immunobiology 2007;212:417-425.
33. Borron PJ, Mostaghel EA, Doyle C, Walsh ES, McHeyzer-Williams MG, Wright JR. Pulmonary surfactant proteins A and D directly suppress CD3(+)/CD4(+) cell function: evidence for two shared mechanisms. J Immunol 2002;169:5844-5850.
34. Tino MJ, Wright JR. Surfactant proteins A and D specifically stimulate directed actin-based responses in alveolar macrophages. Am J Physiol Lung Cell Mol Physiol 1999;276:L164-L174.
35. Takeda K, Miyahara N, Rha YH, Taube C, Yang ES, Joetham A, Kodama T, Balhorn AM, Dakhama A, Duez C, et al. Surfactant protein D regulates airway function and allergic inflammation through modulation of macrophage function. Am J Respir Crit Care Med 2003;168:783-789.
36. Trask B, Malone M, Welgus H, Crouch E, Chang D, Lum E, Shapiro S. Induction of matrix metalloproteinase biosynthesis in human alveolar macrophages exposed to surfactant protein D. Am J Respir Crit Care Med 2000;161:A218.
37. Van Iwaarden J, Shimizu H, Van Golde P, Voelker D, Van Golde L. Rat surfactant protein D enhances the production of oxygen radicals by rat alveolar macrophages. Biochem J 1992;286:5-8.
38. Atochina EN, Beck JM, Preston AM, Haczku A, Tomer Y, Scanlon ST, Fusaro T, Casey J, Hawgood S, Gow AJ, et al. Enhanced lung injury and delayed clearance of Pneumocystis carinii in surfactant protein Adeficient mice: attenuation of cytokine responses and reactive oxygen-nitrogen species. Infect Immun 2004;72:6002-6011.
39. Atochina E, Beers M, Tomer Y, Scanlon S, Russo S, Panettieri RJ, Haczku A. Attenuated allergic airway hyperresponsiveness in C57BL/6 mice is associated with enhanced surfactant protein (SP)-D production following allergic sensitization. Respir Res 2003;4:15-26.
40. Lee P, Alam J, Sylvester S, Inamdar N, Otterbein L, Choi A. Regulation of heme oxygenase-1 expression in vivo and in vitro in hyperoxic lung injury. Am J Respir Cell Mol Biol 1996;14:568.
41. Rahman I, MacNee W. Oxidative stress and regulation of glutathione in lung inflammation. Eur Respir J 2000;16:554.
42. Ishii T, Itoh H, Takahashi S, Sato H, Yanagawa T, Katoh Y, Bannai S, Yamamoto M. Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages. J Biol Chem 2000;275:16029.
43. Venugopal R, Jaiswal A. Nrf2 and Nrf1 in association with Jun proteins regulate antioxidant response element-mediated expression and coordinated induction of genes encoding detoxifying enzymes. Oncogene 1998;17:3156.
44. Alam J, Stewart D, Touchard C, Boinapally S, Choi A, Cook J. Nrf2, a Cap'n Collar transcription factor, regulates induction of the heme oxygenase-1 gene. J Biol Chem 1999;274:26071-26078.
45. Itoh K, Chiba T, Takahashi S, Ishii T, Igarashi K, Katoh Y, Oyake T, Hayashi N, Satoh K, Hatayama I, et al. An Nrf2/Small Maf heterodimer mediates the induction of phase ii detoxifying enzyme genes through antioxidant response elements. Biochem Biophys Res Commun 1997;236:322.
46. Chan K, Kan Y. Nrf2 is essential for protection against acute pulmonary injury in mice. Proc Natl Acad Sci U S A 1999;96:12731-12736.
47. Hayes J, Chanas S, Henderson C, McMahon M, Sun C, Moffat J, Wolff C, Yamamoto M. The Nrf2 transcription factor contributes both to the basal expression of glutathione S-transferases in mouse liver and to their induction by the chemopreventive synthetic antioxidants, butylated hydroxyanisole and ethoxyquin. Biochem Soc Trans 2000;28:41.
48. Cho H-Y, Jedlicka A, Reddy S, Kensler T, Yamamoto M, Zhang L-Y, Kleeberger S. Role of NRF2 in protection against hyperoxic lung injury in mice. Am J Respir Cell Mol Biol 2002;26:175-182.
49. Sies H. Oxidative stress: oxidants and antioxidants. Exp Physiol 1997;82:291-295.
50. Asikainen TM, White CW. Pulmonary antioxidant defenses in the preterm newborn with respiratory distress and bronchopulmonary dysplasia in evolution: implications for antioxidant therapy. Antioxid Redox Signal 2004;6:155-167.
51. Bridges JP, Davis HW, Damodarasamy M, Kuroki Y, Howles G, Hui DY, McCormack FX. Pulmonary surfactant proteins A and D are potent endogenous inhibitors of lipid peroxidation and oxidative cellular injury. J Biol Chem 2000;275:38848-38855.
52. O'Reilly P, Hickman-Davis JM, McArdle P, Young KR, Matalon S. The role of nitric oxide in lung innate immunity: modulation by surfactant protein-A. Mol Cell Biochem 2002;234:39-48.
53. Lawson PR, Perkins VC, Holmskov U, Reid KBM. Genomic organization of the mouse gene for lung surfactant protein D. Am J Respir Cell Mol Biol 1999;20:953-963.
54. Sims M, Tal-Singer R, Kierstein S, Musani A, Beers M, Panettieri R, Haczku A. Chronic obstructive pulmonary disease and inhaled steroids alter surfactant protein D (SP-D) levels: a cross-sectional study. Respir Res 2008;9:13.
55. Greene KE, Wright JR, Steinberg KP, Ruzinski JT, Caldwell E, Wong WB, Hull W, Whitsett JA, Akino T, Kuroki Y, et al. Serial changes in surfactant-associated proteins in lung and serum before and after onset of ARDS. Am J Respir Crit Care Med 1999;160:1843-1850.
56. Strong P, Reid KBM, Clark H. Intranasal delivery of a truncated recombinant human SP-D is effective at down-regulating allergic hypersensitivity in mice sensitized to allergens of Aspergillus fumigatus. Clin Exp Immunol 2002;130:19-24.
57. Clark H, Palaniyar N, Strong P, Edmondson J, Hawgood S, Reid KB. Surfactant protein D reduces alveolar macrophage apoptosis in vivo. J Immunol 2002;169:2892-2899.